Skip directly to search Skip directly to site content

Podcasts at CDC

CDC A-Z Index

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #

Text Size:

Podcast Header CDC Podcast list Podcast Help CDC RSS Feeds RSS Help
Listen to/view CDC podcasts on your computer or download them for reliable health and safety information when and where you want it. New to podcasting? See Podcast Help and RSS Help

Browse by TopicHepatitis B Vaccination

Esta transmisión habla de la importancia de vacunar a los recién nacidos contra la hepatitis B poco después de su nacimiento.  

No se vaya del hospital sin la vacuna (Don’t Leave the Hospital Without It)

Listen to the Podcast Listen To This Podcast (1:14)

Esta transmisión habla de la importancia de vacunar a los recién nacidos contra la hepatitis B poco después de su nacimiento.  Created: 7/31/2008 by MMWR.   Date Released: 7/8/2009.

More info on this topic


Vaccinating newborns with the hepatitis B vaccine is important. In the United States, approximately ninety percent of hepatitis B infections can be prevented in newborns if the hepatitis B vaccine is administered shortly after birth.  

Don't Leave the Hospital Without It (A Cup of Health with CDC)

Listen to the Podcast Listen To This Podcast (3:23)

Vaccinating newborns with the hepatitis B vaccine is important. In the United States, approximately ninety percent of hepatitis B infections can be prevented in newborns if the hepatitis B vaccine is administered shortly after birth.  Created: 8/1/2008 by MMWR.   Date Released: 7/31/2008.

More info on this topic


This broadcast discusses the importance of newborns receiving the hepatitis B vaccine shortly after birth.  

Don't Leave the Hospital Without It (A Minute of Health with CDC)

Listen to the Podcast Listen To This Podcast (0:59)

This broadcast discusses the importance of newborns receiving the hepatitis B vaccine shortly after birth.  Created: 8/1/2008 by MMWR.   Date Released: 7/31/2008.

More info on this topic


This podcast discusses an underappreciated health threat to many Asians and Pacific Islanders in the United States: chronic infection with the hepatitis B virus. Dr. John Ward, director of CDC's Division of Viral Hepatitis, and Dr. Sam So, founder of the Asian Liver Center at Stanford University, address the importance of testing, vaccination, and care to prevent serious health consequences from this   

Stopping the Silent Killer: Hepatitis B Among Asian Americans

Listen to the Podcast Listen To This Podcast (6:22)

This podcast discusses an underappreciated health threat to many Asians and Pacific Islanders in the United States: chronic infection with the hepatitis B virus. Dr. John Ward, director of CDC's Division of Viral Hepatitis, and Dr. Sam So, founder of the Asian Liver Center at Stanford University, address the importance of testing, vaccination, and care to prevent serious health consequences from this "silent" disease.  Created: 4/18/2008 by National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Division of Viral Hepatitis (DVH) and Office of Dispute Resolution and Equal Employment Opportunity, Office of the Director (OD) .   Date Released: 5/1/2008.

More info on this topic


Los virus de la hepatitis aguda A, B y C son objeto de una vigilancia epidemiológica nacional.  Entre 1995 y 2005, las tasas de hepatitis aguda por estos tres tipos de virus disminuyeron en forma drástica. Esta reducción fue una de las consecuencias de la implementación de estrategias de prevención globales para cada enfermedad, entre las que se incluye la disponibilidad de vacunas eficaces contra las hepatitis A y B.   

El “ABC” de la hepatitis

Listen to the Podcast Listen To This Podcast (1:24)

Los virus de la hepatitis aguda A, B y C son objeto de una vigilancia epidemiológica nacional. Entre 1995 y 2005, las tasas de hepatitis aguda por estos tres tipos de virus disminuyeron en forma drástica. Esta reducción fue una de las consecuencias de la implementación de estrategias de prevención globales para cada enfermedad, entre las que se incluye la disponibilidad de vacunas eficaces contra las hepatitis A y B.  Created: 3/2/2007 by MMWR.   Date Released: 1/18/2008.

More info on this topic


National surveillance is conducted for acute hepatitis A, B, and C viruses. During 1995--2005, rates of all three types of acute viral hepatitis declined dramatically. These declines partially resulted from implementation of comprehensive prevention strategies for each disease, including the introduction of effective vaccines against hepatitis A and hepatitis B.  

The ABCs of Hepatitis (A Minute of Health with CDC)

Listen to the Podcast Listen To This Podcast (0:59)

National surveillance is conducted for acute hepatitis A, B, and C viruses. During 1995--2005, rates of all three types of acute viral hepatitis declined dramatically. These declines partially resulted from implementation of comprehensive prevention strategies for each disease, including the introduction of effective vaccines against hepatitis A and hepatitis B.  Created: 3/2/2007 by MMWR.   Date Released: 8/10/2007.

More info on this topic


National surveillance is conducted for acute hepatitis A, B, and C viruses. During 1995--2005, rates of all three types of acute viral hepatitis declined dramatically. These declines partially resulted from implementation of comprehensive prevention strategies for each disease, including the introduction of effective vaccines against hepatitis A and hepatitis B.  

The ABCs of Hepatitis (A Cup of Health with CDC)

Listen to the Podcast Listen To This Podcast (9:34)

National surveillance is conducted for acute hepatitis A, B, and C viruses. During 1995--2005, rates of all three types of acute viral hepatitis declined dramatically. These declines partially resulted from implementation of comprehensive prevention strategies for each disease, including the introduction of effective vaccines against hepatitis A and hepatitis B.  Created: 3/2/2007 by MMWR.   Date Released: 8/10/2007.

More info on this topic


La vacunación contra la hepatitis B es la medida más eficaz para prevenir una infección con el virus de la hepatitis B (VHB) y sus consecuencias, incluyendo cirrosis del hígado, cáncer de hígado, insuficiencia hepática y la muerte. Este informe representa la segunda y última parte de una declaración del Comité Asesor de Prácticas de Inmunización (ACIP, por sus siglas en inglés) y proporciona recomendaciones actualizadas a fin de aumentar la tasa de vacunación contra la hepatitis B en los adultos en mayor riesgo de infección por VHB.  

Estrategia integral de inmunización para eliminar la transmisión de VHB en los Estados Unidos

Listen to the Podcast Listen To This Podcast (1:01)

La vacunación contra la hepatitis B es la medida más eficaz para prevenir una infección con el virus de la hepatitis B (VHB) y sus consecuencias, incluyendo cirrosis del hígado, cáncer de hígado, insuficiencia hepática y la muerte. Este informe representa la segunda y última parte de una declaración del Comité Asesor de Prácticas de Inmunización (ACIP, por sus siglas en inglés) y proporciona recomendaciones actualizadas a fin de aumentar la tasa de vacunación contra la hepatitis B en los adultos en mayor riesgo de infección por VHB.  Created: 4/5/2007 by MMWR.   Date Released: 4/6/2007.

More info on this topic


Hepatitis B vaccination is the most effective measure to prevent hepatitis B virus (HBV) infection and its consequences, including cirrhosis of the liver, liver cancer, liver failure, and death. This report, the second of a two-part statement from the Advisory Committee on Immunization Practices (ACIP), provides updated recommendations to increase hepatitis B vaccination of adults at risk for HBV infection.  

A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States (A Cup of Health with CDC)

Listen to the Podcast Listen To This Podcast (7:56)

Hepatitis B vaccination is the most effective measure to prevent hepatitis B virus (HBV) infection and its consequences, including cirrhosis of the liver, liver cancer, liver failure, and death. This report, the second of a two-part statement from the Advisory Committee on Immunization Practices (ACIP), provides updated recommendations to increase hepatitis B vaccination of adults at risk for HBV infection.  Created: 12/8/2006 by MMWR.   Date Released: 12/15/2006.

More info on this topic


Hepatitis B vaccination is the most effective measure to prevent hepatitis B virus (HBV) infection and its consequences, including cirrhosis of the liver, liver cancer, liver failure, and death. This report, the second of a two-part statement from the Advisory Committee on Immunization Practices (ACIP), provides updated recommendations to increase hepatitis B vaccination of adults at risk for HBV infection.  

A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States (A Minute of Health with CDC)

Listen to the Podcast Listen To This Podcast (1:20)

Hepatitis B vaccination is the most effective measure to prevent hepatitis B virus (HBV) infection and its consequences, including cirrhosis of the liver, liver cancer, liver failure, and death. This report, the second of a two-part statement from the Advisory Committee on Immunization Practices (ACIP), provides updated recommendations to increase hepatitis B vaccination of adults at risk for HBV infection.  Created: 12/8/2006 by MMWR.   Date Released: 12/15/2006.

More info on this topic

  Page last modified July 31, 2009

Safer, Healthier People
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov